Blood test may catch kidney cancer sooner, study hints

NCT ID NCT06917560

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether measuring certain autoantibodies in the blood can help diagnose kidney cancer earlier and predict how the disease will progress. Researchers will analyze data from 400 patients to build a predictive model. The goal is to personalize treatment and avoid unnecessary risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to detect kidney cancer earlier and guide personalized treatment decisions.

What could go wrong

This is a retrospective study analyzing existing data, not a treatment trial. The model may not work as well in real-world settings or different patient groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nonpapillary renal cell carcinoma renal carcinoma renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • first hospital affiliated of Fujian medical university

    Fuzhou, Fujian, 350005, China